Cybin Cash on Hand 2021-2025 | HELP

Cybin cash on hand from 2021 to 2025. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
Cybin Annual Cash on Hand
(Millions of US $)
2025 $97
2024 $155
2023 $13
2022 $43
2021 $49
Cybin Quarterly Cash on Hand
(Millions of US $)
2025-09-30 $84
2025-06-30 $119
2025-03-31 $94
2024-12-31 $97
2024-09-30 $113
2024-06-30 $134
2024-03-31 $155
2023-12-31 $29
2023-09-30 $14
2023-06-30 $7
2023-03-31 $13
2022-12-31 $17
2022-09-30 $23
2022-06-30 $33
2022-03-31 $43
2021-12-31 $50
2021-09-30 $60
2021-06-30 $45
2020-12-31 $31
Sector Industry Market Cap Revenue
Medical MED-DRUGS $0.298B $0.000B
Helus Pharma is a clinical stage pharmaceutical company. Its lead candidate includes HLP003 and HLP004. Helus Pharma, formerly known as Cybin Inc., is based in BOSTON.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) JP $92.346B 32.25
Takeda Pharmaceutical (TAK) JP $56.926B 11.18
Zoetis (ZTS) US $56.153B 20.10
BeOne Medicines - (ONC) CH $38.812B 205.77
Sandoz Group AG (SDZNY) CH $35.065B 0.00
Daiichi Sankyo, - (DSNKY) JP $34.401B 0.00
United Therapeutics (UTHR) US $20.898B 18.39
Merck (MKKGY) DE $18.714B 11.54
Shionogi (SGIOY) JP $18.571B 14.36
Neurocrine Biosciences (NBIX) US $14.078B 33.78
Ionis Pharmaceuticals (IONS) US $14.011B 0.00
IPSEN (IPSEY) FR $13.491B 0.00
Summit Therapeutics (SMMT) US $11.560B 0.00
Orion OYJ (ORINY) FI $11.502B 32.86
Madrigal Pharmaceuticals (MDGL) US $10.847B 0.00
Eisai (ESAIY) $8.574B 0.00
Ono Pharmaceutical (OPHLF) JP $7.149B 17.10
Stevanato Group S.p.A (STVN) IT $4.694B 26.27
Crinetics Pharmaceuticals (CRNX) US $4.626B 0.00
Hikma Pharmaceuticals Plc (HKMPF) GB $4.591B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) US $4.565B 21.67
Indivior Pharmaceuticals (INDV) US $4.296B 17.53
Corcept Therapeutics (CORT) US $4.295B 46.40
NewAmsterdam Pharma (NAMS) NL $3.889B 0.00
Centessa Pharmaceuticals (CNTA) GB $3.158B 0.00
Catalyst Pharmaceuticals (CPRX) US $3.004B 9.58
Hypermarcas (HYPMY) BR $2.755B 18.91
Dyne Therapeutics (DYN) US $2.399B 0.00
Soleno Therapeutics (SLNO) US $2.231B 0.00
Guardian Pharmacy Services (GRDN) US $2.145B 41.32
Avadel Pharmaceuticals (AVDL) IE $2.118B 0.00
Ocular Therapeutix (OCUL) US $1.994B 0.00
Aurinia Pharmaceuticals Inc (AUPH) CA $1.904B 22.56
Ardelyx (ARDX) US $1.779B 0.00
Harrow (HROW) US $1.753B 107.54
Enliven Therapeutics (ELVN) US $1.746B 0.00
Definium Therapeutics (DFTX) US $1.665B 0.00
Oruka Therapeutics (ORKA) US $1.600B 0.00
Relay Therapeutics (RLAY) US $1.546B 0.00
Amylyx Pharmaceuticals (AMLX) US $1.535B 0.00
Collegium Pharmaceutical (COLL) US $1.505B 7.45
BioCryst Pharmaceuticals (BCRX) US $1.345B 79.75
Evotec AG (EVO) DE $1.254B 0.00
Xeris Biopharma Holdings (XERS) US $1.163B 0.00
Savara (SVRA) US $1.078B 0.00
Theravance Biopharma (TBPH) US $1.038B 43.57
Cronos Group (CRON) CA $1.004B 0.00
ARS Pharmaceuticals (SPRY) US $0.991B 0.00
Aktis Oncology (AKTS) US $0.961B 0.00
Xencor (XNCR) US $0.829B 0.00
Esperion Therapeutics (ESPR) US $0.813B 0.00
KalVista Pharmaceuticals (KALV) US $0.753B 0.00
Nektar Therapeutics (NKTR) US $0.749B 0.00
Ironwood Pharmaceuticals (IRWD) US $0.742B 17.54
Bioventus (BVS) US $0.704B 14.42
Rigel Pharmaceuticals (RIGL) US $0.620B 5.53
ProKidney (PROK) US $0.563B 0.00
Altimmune (ALT) US $0.550B 0.00
Lexeo Therapeutics (LXEO) US $0.523B 0.00
4D Molecular Therapeutics (FDMT) US $0.514B 0.00
Aquestive Therapeutics (AQST) US $0.501B 0.00
Zevra Therapeutics (ZVRA) US $0.484B 0.00
Lyell Immunopharma (LYEL) US $0.482B 0.00
Elite Pharmaceuticals (ELTP) US $0.481B 0.00
Siga Technologies (SIGA) US $0.480B 6.57
Organogenesis (ORGO) US $0.478B 0.00
Nature's Sunshine Products (NATR) US $0.461B 27.43
USANA Health Sciences (USNA) US $0.390B 10.89
Aclaris Therapeutics (ACRS) US $0.387B 0.00
Akebia Therapeutics (AKBA) US $0.369B 0.00
Protara Therapeutics (TARA) US $0.343B 0.00
Aldeyra Therapeutics (ALDX) US $0.333B 0.00
Relmada Therapeutics (RLMD) US $0.285B 0.00
Larimar Therapeutics (LRMR) US $0.279B 0.00
Journey Medical (DERM) US $0.278B 0.00
Enlivex Therapeutics (ENLV) IL $0.275B 0.00
Avalo Therapeutics (AVTX) US $0.263B 0.00
OmniAb (OABI) US $0.245B 0.00
Profound Medical (PROF) CA $0.236B 0.00
Heron Therapeutics (HRTX) US $0.231B 0.00
MediWound (MDWD) IL $0.228B 0.00
Achieve Life Sciences (ACHV) CA $0.226B 0.00
Silence Therapeutics (SLN) GB $0.224B 0.00
Context Therapeutics (CNTX) US $0.209B 0.00
Minerva Neurosciences (NERV) US $0.208B 0.00
Tonix Pharmaceuticals Holding (TNXP) US $0.199B 0.00
Surrozen (SRZN) US $0.195B 0.00
Innate Pharma SA (IPHYF) FR $0.181B 0.00
Galectin Therapeutics (GALT) US $0.181B 0.00
AleAnna (ANNA) US $0.179B 0.00
Century Therapeutics (IPSC) US $0.149B 0.00
VAXART, INC (VXRT) US $0.146B 0.00
Unicycive Therapeutics (UNCY) US $0.144B 0.00
Corbus Pharmaceuticals Holdings (CRBP) US $0.137B 0.00
Prelude Therapeutics (PRLD) US $0.136B 0.00
Inhibikase Therapeutics (IKT) US $0.128B 0.00
Avita Medical (RCEL) US $0.119B 0.00
Korro Bio (KRRO) US $0.118B 0.00
Karyopharm Therapeutics (KPTI) US $0.115B 0.00
Cardiol Therapeutics (CRDL) CA $0.111B 0.00
Verrica Pharmaceuticals (VRCA) US $0.110B 0.00
Incannex Healthcare (IXHL) AU $0.100B 0.00
Vivani Medical (VANI) US $0.098B 0.00
Cassava Sciences (SAVA) US $0.098B 0.00
Pyxis Oncology (PYXS) US $0.094B 0.00
Champions Oncology (CSBR) US $0.091B 38.53
Assertio Holdings (ASRT) US $0.082B 0.00
PolyPid (PYPD) IL $0.072B 0.00
HST Global (HSTC) US $0.069B 0.00
Gain Therapeutics (GANX) US $0.067B 0.00
Rafael Holdings (RFL) US $0.063B 0.00
Dominari Holdings (DOMH) US $0.061B 0.00
Cumberland Pharmaceuticals (CPIX) US $0.058B 48.88
Procaps Group, S.A (PROCF) LU $0.058B 0.00
Fractyl Health (GUTS) US $0.057B 0.00
NRx Pharmaceuticals (NRXP) US $0.057B 0.00
BioNxt Solutions (BNXTF) CA $0.056B 0.00
PMV Pharmaceuticals (PMVP) US $0.055B 0.00
Nutriband (NTRB) US $0.053B 0.00
Acrivon Therapeutics (ACRV) US $0.053B 0.00
Liminatus Pharma (LIMN) US $0.050B 0.00
Lipocine (LPCN) US $0.047B 0.00
ElectroCore (ECOR) US $0.044B 0.00
Telomir Pharmaceuticals (TELO) US $0.040B 0.00
FibroGen (FGEN) United States $0.039B 0.00
Lite Strategy (LITS) US $0.039B 0.00
Talphera (TLPH) US $0.038B 0.00
Plus Therapeutics (PSTV) US $0.036B 0.00
Mural Oncology (MURA) Ireland $0.035B 0.00
Reviva Pharmaceuticals Holdings (RVPH) US $0.033B 0.00
SCYNEXIS (SCYX) US $0.032B 0.00
Wellgistics Health (WGRX) US $0.028B 0.00
MARKER THERAPEUTICS, INC (MRKR) US $0.028B 0.00
TherapeuticsMD (TXMD) US $0.027B 0.00
Jupiter Neurosciences (JUNS) US $0.021B 0.00
Natural Alternatives (NAII) US $0.020B 0.00
Scienture Holdings (SCNX) US $0.019B 0.00
VYNE Therapeutics (VYNE) US $0.019B 0.00
Klotho Neurosciences (KLTO) US $0.018B 0.00
Cosmos Health (COSM) US $0.017B 0.00
Iterum Therapeutics (ITRM) IE $0.016B 0.00
Citius Pharmaceuticals (CTXR) US $0.016B 0.00
Traws Pharma (TRAW) US $0.016B 0.02
Vyome Holdings (HIND) US $0.015B 0.00
Vivos Therapeutics (VVOS) US $0.015B 0.00
Inotiv (NOTV) US $0.014B 0.00
Mannatech (MTEX) US $0.014B 0.00
BioLineRx (BLRX) IL $0.013B 0.00
Tempest Therapeutics (TPST) US $0.012B 0.00
CASI Pharmaceuticals (CASI) CN $0.011B 0.00
Phio Pharmaceuticals (PHIO) US $0.010B 0.00
Addex Therapeutics (ADXN) CH $0.010B 0.00
XTL Biopharmaceuticals (XTLB) IL $0.009B 0.00
Ainos (AIMD) US $0.009B 0.00
BioVie (BIVI) US $0.009B 0.00
TransCode Therapeutics (RNAZ) US $0.008B 0.00
Kiora Pharmaceuticals (KPRX) US $0.008B 0.00
Curanex Pharmaceuticals Inc (CURX) US $0.008B 0.00
Nuvilex (PMCB) US $0.008B 0.00
Biomerica (BMRA) US $0.007B 0.00
Mangoceuticals (MGRX) US $0.006B 0.00
Alaunos Therapeutics (TCRT) US $0.006B 0.00
Quoin Pharmaceuticals (QNRX) US $0.006B 0.00
Redhill Biopharma (RDHL) IL $0.005B 0.00
Heatwurx (PCSA) US $0.005B 0.00
Sonoma Pharmaceuticals (SNOA) US $0.005B 0.00
Aptorum Group (APM) GB $0.005B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.005B 0.00
Xenetic Biosciences (XBIO) US $0.005B 0.00
60 Degrees Pharmaceuticals (SXTP) US $0.004B 0.00
Indaptus Therapeutics (INDP) US $0.004B 0.00
Lyra Therapeutics (LYRA) US $0.003B 0.00
Ernexa Therapeutics (ERNA) US $0.003B 0.00
China SXT Pharmaceuticals (SXTC) CN $0.003B 0.00
XORTX Therapeutics (XRTX) CA $0.003B 0.00
InMed Pharmaceuticals (INM) CA $0.003B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) US $0.003B 0.00
Jaguar Animal Health (JAGX) US $0.003B 0.00
SciSparc (SPRC) IL $0.002B 0.00
Universe Pharmaceuticals INC (UPC) CN $0.002B 0.00
Clearmind Medicine (CMND) CA $0.002B 0.00
CDT Equity (CDT) US $0.002B 0.00
Galmed Pharmaceuticals (GLMD) IL $0.001B 0.00
Aditxt (ADTX) US $0.000B 0.00
Emisphere Technologies (EMIS) US $0.000B 0.00
Grifols, S.A (GRFS) ES $0.000B 0.00
4D Pharma (LBPS) GB $0.000B 0.00
PainReform (PRFX) IL $0.000B 0.00
Patheon (PTHN) NL $0.000B 0.00
RVL Pharmaceuticals (RVLP) US $0.000B 0.00